XLON
CVSG
Market cap1.16bUSD
Dec 05, Last price
1,214.00GBP
1D
0.83%
1Q
-0.98%
Jan 2017
10.06%
IPO
419.91%
Name
CVS Group PLC
Chart & Performance
P/E
140.47
P/S
1.35
EPS
0.09
Div Yield, %
0.66%
Shrs. gr., 5y
0.30%
Rev. gr., 5y
9.75%
Revenues
647m
+6.41%
Net income
6m
-85.20%
CFO
68m
-19.76%
Dividend
Oct 31, 20248 GBP/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CVS Group plc engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail. It operates animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation and clinical waste services for veterinary practices. In addition, it operates Animed Direct, an online pharmacy and retail business that sells prescription and non-prescription medicines, premium pet foods, and other pet care products; and an online dispensary. Further, the company provides burial grounds; and veterinary instrumentation supply and referral services. It owns 506 veterinary practices, 3 laboratories, 7 crematoria, and an online pharmacy. CVS Group plc was founded in 1999 and is based in Diss, the United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||